IMO, the company has to start the new year as if the FDA approval doesn't exist. It seems to me there are plenty of reasons, including approvals in the rest of the world, solid financials, deals, orders and partnerships to propel us to NASDAQ. It's a cinch those FDA gumballs are going to start the new year with sleep sludge in their eyes and cobwebs on the brain. The company should focus on other means to get us where we have to be. Hanging our hats on bureuacratics to save the day just might be detrimental to our health.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.